一线抗逆转录病毒治疗方案对CNICS队列中CD4/CD8比值恢复的影响
该临床队列研究纳入3971例接受ART且达到病毒学抑制的HIV初治成人,比较NNRTI、PI和INSTI方案对CD4/CD8比值恢复的影响。调整混杂因素后,NNRTI组CD4/CD8比值增益显著大于PI组,INSTI组在≥1.0 cut-off的比值正常化率高于PI组。
要点
- NNRTI方案较PI方案带来更大的CD4/CD8比值增益
- NNRTI和INSTI方案在比值≥1.0的正常化率上高于PI方案
- NNRTI组的比值改善主要由CD8计数下降更多驱动
核心结论
- NNRTI治疗与比PI更大幅度的CD4/CD8比值增加相关。
- 基于NNRTI和INSTI的一线ART在CD4/CD8比值≥1.0的正常化率上高于基于PI的方案。
研究设计与样本
- CNICS临床队列研究,纳入3971例接受ART的HIV初治成人。
- 入选者需在治疗前48周内达到HIV RNA检测不到,并在病毒学抑制后随访48周。
主要发现
- 1876例起始NNRTI,1804例起始PI,291例起始INSTI。
- 调整年龄、性别、种族、入组年份、风险组、HCV血清状态、基线病毒载量和基线CD4/CD8比值后,NNRTI组在ART起始后48周或HIV RNA抑制后48周的CD4/CD8比值增益均显著大于PI组。
- NNRTI组比值改善更大由CD8计数下降更多驱动。
- INSTI组在≥1.0 cut-off的CD4/CD8比值正常化率高于PI组。
关键数值与推荐
- 主要终点为两个时间点的CD4/CD8比值增加;次要终点为CD4/CD8比值恢复至≥0.5或≥1.0。
临床怎么用
- 选择一线ART方案时可考虑不同方案对CD4/CD8比值恢复的差异,NNRTI和INSTI方案在比值正常化方面可能优于PI方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The CD4/CD8 ratio is an indicator of immunosenescence and a predictor of all-cause mortality in HIV-infected patients. The effects of different ART regimens on CD4/CD8 ratio recovery remain unclear. METHODS: Clinical cohort study of ART-treated patients from the CFAR Network of Integrated Clinical Systems (CNICS). We included ART-naive adults with HIV infection who achieved undetectable HIV RNA during the first 48 weeks of treatment and had additional follow-up 48 weeks after virological suppression (VS). Primary endpoints included increase in CD4/CD8 ratio at both timepoints and secondary endpoints were CD4/CD8 ratio recovery at cut-offs of ≥0.5 or ≥1.0. RESULTS: Of 3971 subjects who met the study criteria, 1876 started ART with an NNRTI, 1804 with a PI and 291 with an integrase strand transfer inhibitor (INSTI). After adjusting for age, sex, race, year of entry, risk group, HCV serostatus, baseline viral load and baseline CD4/CD8 ratio, subjects on an NNRTI showed a significantly greater CD4/CD8 ratio gain compared with those on a PI, either 48 weeks after ART initiation or after 48 weeks of HIV RNA VS. The greater CD4/CD8 ratio improvement in the NNRTI arm was driven by a higher decline in CD8 counts. The INSTI group showed increased rates of CD4/CD8 ratio normalization at the ≥1.0 cut-off compared with the PI group. CONCLUSIONS: NNRTI therapy was associated with a greater increase in the CD4/CD8 ratio compared with PIs. NNRTI- and INSTI-based first-line ART were associated with higher rates of CD4/CD8 ratio normalization at a cut-off of 1.0 than a PI-based regimen, which might have clinical implications.
引用
- Herrera S, Fernandez-Felix BM, Hunt PW, et al. Impact of first-line antiretroviral therapy regimens on the restoration of the CD4/CD8 ratio in the CNICS cohort. J Antimicrob Chemother. 2020. PMID: 32211777. doi:10.1093/jac/dkaa024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。